1. Dawood, A.A., 2023. The efficacy of Paxlovid against COVID-19 is the result of the tight molecular docking between M^pro and antiviral drugs (nirmatrelvir and ritonavir). Adv. Med. Sci., 68: 1-9.
   CrossRef  |  Direct Link  |  
2. Dawood, A.A., B.I. Jasim and O.R. Al-Jalily, 2022. Identification of Surface Glycoprotein Mutations of SARS-CoV-2 in Isolated Strains from Iraq. Med. immunol., 24: 729-740.
   CrossRef  |  Direct Link  |  
3. Dawood, A.A., Al-Rrassam, A.Z. Thanoon and M. Abduljabar, 2022. Did the SARS-CoV-2 come from wild, mutagenic or artificial type? Complete genome analysis. Res. J. Sci. Technol., 14: 21-29.
   Direct Link  |  
4. Dawood, A.A., 2022. Influence of SARS-CoV-2 variants spike glycoprotein and RNA-dependent RNA polymerase (nsp12) mutations on remdesivir docking residues. Med. immunol., 24: 617-628.
   CrossRef  |  Direct Link  |  
5. Dawood, A.A., 2022. Increasing the frequency of omicron variant mutations boosts the immune response and may reduce the virus virulence. Micro. Pathogen., Vol. 164. 10.1016/j.micpath.2022.105400.
   CrossRef  |  Direct Link  |  
6. Dawood, A.A., 2022. Implementation of immuno-chemoinformatics approaches to construct multi-epitope for vaccine development against Omicron and Delta SARS-CoV-2 variants [Spanish]. Vacunas, 23: S18-S31.
   CrossRef  |  Direct Link  |  
7. Dawood, A.A., 2022. Hepatitis B Virus, Genotypes and Subtypes. In: Hepatitis B. Rodrigo, L., (Eds)., IntechOpen U.K. pp: 1.
   CrossRef  |  Direct Link  |  
8. Dawood, A.A., 2022. Enhancement of antibodies neutralize omicron variants in the presence of booster vaccine doses and monoclonal antibodies. Res. J. Sci. Technol., 14: 95-97.
   CrossRef  |  Direct Link  |  
9. Altai, H., M. Altobje and A. Dawood, 2022. The effect of ganoderma lucidum powder on some immune parameters in rat. Rafidain J. Sci., 31: 1-10.
   CrossRef  |  Direct Link  |  
10. Dawood, A.A., M.A.A. Altobje and Z.T. Alrassam, 2021. Elevation of BSF-2 level in serum of patients with hepatitis B virus. Med. immunol., 23: 87-94.
    CrossRef  |  Direct Link  |  
11. Dawood, A.A., M.A.A. Altobje and Z.T. Al-Rrassam, 2021. Molecular docking of sars-cov-2 nucleocapsid protein with angiotensin-converting enzyme II. Mikrobiol. Z., 83: 82-92.
    CrossRef  |  Direct Link  |  
12. Dawood, A.A., M.A. Altobje and H. Abdul-Malik Alnori, 2021. Compatibility of the ligand binding sites in the spike glycoprotein of covid-19 with those in the aminopeptidase and the caveolins 1, 2 proteins. Res. J. Pharm. Technol., 14: 4760-4766.
    CrossRef  |  Direct Link  |  
13. Dawood, A.A., 2021. What do you know about the second wave of covid-19? Res. J. Sci. Technol., 11: 218-220.
    CrossRef  |  Direct Link  |  
14. Dawood, A.A., 2021. Using remdesivir and dexamethasone for treatment of sars-cov-2 shortens the patients stay in the hospital. Asian J. Pharmaceut. Res., 11: 138-140.
    CrossRef  |  Direct Link  |  
15. Dawood, A.A., 2021. Transmission of SARS CoV-2 virus through the ocular mucosa worth taking precautions [Spanish]. Vacunas, 22: 56-57.
    CrossRef  |  Direct Link  |  
16. Dawood, A.A., 2021. The russian vaccine of covid-19 (sputnik v) has shown side effects on the volunteers. Asian J. Res. Pharmaceut. Sci., 11: 193-194.
    CrossRef  |  Direct Link  |  
17. Dawood, A.A., 2021. The effects of the russian vaccine (Sputnik V) on the volunteers. Apollo Med., 18: 52-53.
    CrossRef  |  Direct Link  |  
18. Dawood, A.A., 2021. Reasons for discontinuing the use of hydroxychloroquine in the treatment of the novel coronavirus. Asian J. Pharmaceut. Ana., 11: 179-180.
    CrossRef  |  Direct Link  |  
19. Dawood, A.A., 2021. Identification of cytotoxic t-cell and b-cell epitopes in the nucleocapsid phosphoprotein of SARS-cov-2 using immunoinformatics. Mikrobiol. Z., 83: 78-86.
    CrossRef  |  Direct Link  |  
20. Dawood, A.A., 2021. Glycosylation, ligand binding sites and antigenic variations between membrane glycoprotein of COVID-19 and related coronaviruses. Vacunas, 22: 1-9.
    CrossRef  |  Direct Link  |  
21. Dawood, A.A., 2021. COVID-19: What are the precautionary measures that you do if you travel to a country with the epidemic? Vet. Med. Public Health J., 2: 23-24.
    CrossRef  |  Direct Link  |  
22. Dawood, A.A. and M.A. Altobje, 2020. Inhibition of N-linked glycosylation by tunicamycin may contribute to the treatment of SARS-CoV-2. Microb. Pathogen., Vol. 149. 10.1016/j.micpath.2020.104586.
    CrossRef  |  Direct Link  |  
23. Dawood, A. and H. Abdul-Malik Alnori, 2020. Tunicamycin anticancer drug may reliable to treat coronavirus disease-19. Open Access Maced. J. Med. Sci., 8: 129-133.
    CrossRef  |  Direct Link  |  
24. Dawood, A., 2019. Different vectors used to transform and clone of nonstructural NS1 gene of Influenza B in Escherichia coli. Iraqi J. Vet. Sci., 33: 329-333.
    CrossRef  |  Direct Link  |